iSpeak Blog
Globally, there is an increase in approved advanced therapy medicinal products (ATMPs), with thousands of therapies currently in various stages of pre-clinical and clinical development.
Shanshan Liu
No Deviation Pte Ltd
Director
Shanshan Liu is the current Technical Director at No deviation, responsible for the company's technology and innovation roadmap, as well as the professional growth of employees. She also sits on the Core Team, defining the company's international growth and business strategy. She received her M.Sc. in Biochemical Engineering from the University of Birmingham and brings an international perspective to her work from her experiences in various continents.
Throughout her 18-year career, Shanshan has held various technical roles within consulting firms and major pharmaceutical companies, including Novartis, where she worked within the Global Engineering organization and gained exposure to well established engineering and quality systems. With a solid technical background, Shanshan expanded her expertise into the Quality, Compliance, and Regulatory domains, where she has assisted pharmaceutical and medical device manufacturers in establishing quality systems, remediating quality, and compliance risks, and forming regulatory strategies. Through these projects, Shanshan has developed close collaborations with manufacturers, associations, and international regulators.
Shanshan is passionate about continued education and knowledge sharing. She has been serving as President of the ISPE Singapore Affiliate for the past years and is the current Chair of the ISPE APCA Council. She is also actively involved in other working groups, such as the Drug Shortage Initiative Team. To further share her knowledge, Shanshan is qualified as an ISPE instructor for various modules, i.e. C&Q and ATMP.
Throughout her 18-year career, Shanshan has held various technical roles within consulting firms and major pharmaceutical companies, including Novartis, where she worked within the Global Engineering organization and gained exposure to well established engineering and quality systems. With a solid technical background, Shanshan expanded her expertise into the Quality, Compliance, and Regulatory domains, where she has assisted pharmaceutical and medical device manufacturers in establishing quality systems, remediating quality, and compliance risks, and forming regulatory strategies. Through these projects, Shanshan has developed close collaborations with manufacturers, associations, and international regulators.
Shanshan is passionate about continued education and knowledge sharing. She has been serving as President of the ISPE Singapore Affiliate for the past years and is the current Chair of the ISPE APCA Council. She is also actively involved in other working groups, such as the Drug Shortage Initiative Team. To further share her knowledge, Shanshan is qualified as an ISPE instructor for various modules, i.e. C&Q and ATMP.
Related Articles
iSpeak Blog
Addressing the unmet healthcare & medical needs is among the top priorities for global governments and organisations, including the pharmaceutical industry. We are facing unprecedented challenges due to the change with medical knowledge doubling every 72 days1
- 1Peter Densen, “Challenges and Opportunities Facing Medical Education,” Transactions of the...